中药干预HMGB1通路改善2型糖尿病及其并发症的研究进展
卢爱琳 , 袁梦蕊 , 吴永青 , 刘弘毅
中国临床药理学与治疗学 ›› 2026, Vol. 31 ›› Issue (6) : 827 -835.
中药干预HMGB1通路改善2型糖尿病及其并发症的研究进展
Progress of Chinese medicine intervention in HMGB1 pathway to im- prove type 2 diabetes mellitus and its complications
2 型糖尿病(type 2 diabetes mellitus,T2DM)的发生与胰岛素抵抗和胰岛 β 细胞功能障碍密切相关,高迁移率族蛋白 B1(high mobility group box 1,HMGB1)及其调控的相关受体和信号通路在 T2DM 及其并发症的发生发展中具有重要作用。HMGB1 是炎症反应中的核心调节因子,广泛存在于肝脏、脂肪、骨骼肌以及胰岛等各类组织器官当中,主要通过增强炎症反应和加剧胰岛素抵抗等方式影响 T2DM 的病程。近年来,多种中药被证明可通过调控 HMGB1 及其相关受体和信号通路的表达,延缓 T2DM 及其并发症的进展。本文针对中药干预 HMGB1 通路改善 T2DM 及其并发症的国内外研究现状展开论述,旨在为未来运用中医药治疗 T2DM 及其相关并发症提供用药思路。
The development of type2 diabetes mellitus (T2DM) is closely related to insulin resistance and pancreatic β-cell dysfunction, and high mobility group box 1 (HMGB1) and its related receptors and signaling pathways play an important role in the development of T2DM and its complications. HMGB1 is a core regulator of inflammatory response, widely found in various tissues and organs such as liver, adipose, skeletal muscle, and pancreatic islets, and affects the course of T2DM by enhancing inflammatory response and exacerbating insulin resistance. In recent years, a variety of traditional Chinese medicines (TCM) have been shown to slow down the progression of T2DM and its complications by regulating the expression of HMGB1 and its related receptors and signaling pathways. Therefore, the article discusses the current status of domestic and international research on the intervention of Chinese medicines in the HMGB1 pathway to improve T2DM and its complications, with the aim of providing medication ideas for the future use of Chinese medicines in the treatment of T2DM and its related complications.
| [1] |
|
| [2] |
|
| [3] |
Behl T, Sharma E, Sehgal A, |
| [4] |
|
| [5] |
唐虹, 李林霞, 华宇, |
| [6] |
|
| [7] |
亢丽娟, 董海平, 宋艳艳. 栀子苷调节 HMGB1-RAGE 信号通路对妊娠期糖尿病大鼠胰岛素抵抗的影响[J].解剖学研究, 2024, 46(2): 176-182+190. |
| [8] |
|
| [9] |
马静, 王齐, 陈彩玲, |
| [10] |
王雅清, 王勇, 刘永胜. 芦丁调控 miR-155 和 HMGB1/RAGE 通路对糖尿病视网膜病变大鼠炎性反应的影响[J].陕西医学杂志, 2024, 53(2): 184-188. |
| [11] |
|
| [12] |
|
| [13] |
潘娟, 王琪, 田艳妮. 甘草甜素调节 HMGB1/RAGE 信号通路对高糖诱导的心肌细胞凋亡和自噬的影响[J].中西医结合心脑血管病杂志, 2024, 22(11): 1961-1966. |
| [14] |
|
| [15] |
|
| [16] |
|
| [17] |
姜一凡, 李小荣, 耿嘉逸, |
| [18] |
傅永锦, 夏雪怡, 张小牧, |
| [19] |
|
| [20] |
|
| [21] |
孙跃先, 王九妹, 崔新刚, |
| [22] |
|
| [23] |
郑领涛, 申妍姣, 宋丽明. 连翘苷抑制 HMGB1/RAGE 信号通路减轻大鼠糖尿病周围神经病变坐骨神经损伤[J].免疫学杂志, 2024, 40(1): 46-52. |
| [24] |
|
| [25] |
|
| [26] |
|
| [27] |
|
| [28] |
孟宏, 王桂青, 杜竹君. 西红花苷通过调控 TLR4/MyD88/NF-κB 通路改善糖尿病大鼠视网膜病变机制研究[J].陕西医学杂志, 2023, 52(5): 531-535+540. |
| [29] |
高明, 徐丽丽, 王利存, |
| [30] |
朱素华. 芍药苷抑制糖尿病视网膜病变基质金属蛋白酶 9 激活的研究[D].南京:南京医科大学, 2017. |
| [31] |
|
| [32] |
孟昭昀, 张燕群, 王秀玲, |
| [33] |
Zhu Z, |
| [34] |
|
| [35] |
|
| [36] |
边咏馨. 牛磺酸对糖尿病肾病预防作用的研究[D].沈阳:沈阳农业大学, 2020. |
| [37] |
|
| [38] |
熊刚, 邹华, 胡承莲, |
| [39] |
|
| [40] |
何流, 金智生, 张磊, |
| [41] |
|
| [42] |
许月娇. 香青兰总黄酮对 T2DM 大鼠胰岛功能的影响及作用机制研究[J].湖北科技学院学报 (医学版), 2021, 35(6): 465-468+474+456. |
| [43] |
|
| [44] |
Liu B, Li S, Sui X, |
| [45] |
袁小波, 彭小珊, 周丽丽, |
| [46] |
尹延航, 陈绪才, 王益, |
| [47] |
凌佼佼, 栾兰, 杨芳, |
| [48] |
韦艳, 李红, 苏晓庆, |
| [49] |
|
| [50] |
|
| [51] |
|
| [52] |
|
| [53] |
刘思妤, 刘青, 彭群龙, |
| [54] |
|
| [55] |
|
| [56] |
马洪海. 黄芪甲苷纳米混悬剂的制备与评价及对糖尿病肾病的治疗[D].哈尔滨:哈尔滨商业大学, 2021. |
| [57] |
谢莹, 林鑫, 袁静, |
| [58] |
|
| [59] |
|
| [60] |
|
国家自然科学基金-地区科学基金项目(82360919)
云南科技厅中医联合面上项目(202301AZ070001-066)
云南省卫健委高层次中医药人才培养工作项目()
/
| 〈 |
|
〉 |